8102
-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Therapeutics and Clinical Risk Management
(2,215,697) Views
Editor in Chief Professor Garry Walsh
1178-203X
Shared decision-making based on different features of risk in the context of diabetes mellitus and rheumatoid arthritis
Monica Ortendahl
Therapeutics and Clinical Risk Management 2007, 3:1175-1180
17 January 2007
Update on the treatment of disseminated fusariosis: Focus on voriconazole
Marta Stanzani, Fabio Tumietto, Nicola Vianelli, Michele Baccarani
Therapeutics and Clinical Risk Management 2007, 3:1165-1173
17 January 2007
Treatment of non-alcoholic fatty liver disease
Keith G Tolman, Anthony S Dalpiaz
Therapeutics and Clinical Risk Management 2007, 3:1153-1163
17 January 2007
History and evolution of antibiotic resistance in coagulase-negative staphylococci: Susceptibility profiles of new anti-staphylococcal agents
Joseph F John, Alexander M Harvin
Therapeutics and Clinical Risk Management 2007, 3:1143-1152
17 January 2007
Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma
Todd M Cooper
Therapeutics and Clinical Risk Management 2007, 3:1135-1141
17 January 2007
Update on the treatment of ankylosing spondylitis
Walter P Maksymowych
Therapeutics and Clinical Risk Management 2007, 3:1125-1133
17 January 2007
Rivastigmine in Alzheimer’s disease: Cognitive function and quality of life
Roberta Annicchiarico, Alessia Federici, Carla Pettenati, Carlo Caltagirone
Therapeutics and Clinical Risk Management 2007, 3:1113-1123
17 January 2007
Obstructive sleep apnea and cardiovascular risk
Punginathn Dorasamy
Therapeutics and Clinical Risk Management 2007, 3:1105-1111
17 January 2007
Review of tenofovir-emtricitabine
Saba Woldemichael Masho, Cun-Lin Wang, Daniel E Nixon
Therapeutics and Clinical Risk Management 2007, 3:1097-1104
17 January 2007
Topotecan: An evolving option in the treatment of relapsed small cell lung cancer
Jennifer Garst
Therapeutics and Clinical Risk Management 2007, 3:1087-1095
17 January 2007
The role of entecavir in the treatment of chronic hepatitis B
Evangelini Dimou, Vasilios Papadimitropoulos, Stephanos J Hadziyannis
Therapeutics and Clinical Risk Management 2007, 3:1077-1086
17 January 2007
Vaccination against hepatitis A in children: A review of the evidence
Paolo Bonanni, Sara Boccalini, Angela Bechini
Therapeutics and Clinical Risk Management 2007, 3:1071-1076
17 January 2007
Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections
Mary L Townsend, Melanie W Pound, Richard H Drew
Therapeutics and Clinical Risk Management 2007, 3:1059-1070
17 January 2007
Optimizing medicines management: From compliance to concordance
Annie Cushing, Richard Metcalfe
Therapeutics and Clinical Risk Management 2007, 3:1047-1058
17 January 2007
Barrett’s esophagus: Incidence, etiology, pathophysiology, prevention and treatment
Nir Modiano, Lauren B Gerson
Therapeutics and Clinical Risk Management 2007, 3:1035-1045
17 January 2007
Management of patients with newly diagnosed malignant primary brain tumors with a focus on the evolving role of temozolomide
Mark R Gilbert, Terri S Armstrong
Therapeutics and Clinical Risk Management 2007, 3:1027-1033
17 January 2007
Treatment of atopic dermatitis with pimecrolimus – impact on quality of life
Hae-Hyuk Lee, Torsten Zuberbier, Margitta Worm
Therapeutics and Clinical Risk Management 2007, 3:1021-1026
17 January 2007
Palonosetron as an anti-emetic and anti-nausea agent in oncology
Matti S Aapro
Therapeutics and Clinical Risk Management 2007, 3:1009-1020
17 January 2007
Photodynamic diagnosis for follow-up of carcinoma in situ of the bladder
Renzo Colombo, Richard Naspro, Piera Bellinzoni, Fabio Fabbri, Giorgio Guazzoni, et al
Therapeutics and Clinical Risk Management 2007, 3:1003-1007
17 January 2007
Association between homocysteinemia and metabolic syndrome in patients with cardiovascular disease
Chiara Bellia, Giulia Bivona, Concetta Scazzone, Marcello Ciaccio
Therapeutics and Clinical Risk Management 2007, 3:999-1001
17 January 2007
Impact of Pharmaceutical Care interventions in the identification and resolution of drug-related problems and on quality of life in a group of elderly outpatients in Ribeirão Preto (SP), Brazil
Divaldo Pereira de Lyra Júnior, Nadir Kheir, Juliana Palma Abriata, Chiara Ermínia da Rocha, Cláudia Benedita dos Santos, et al
Therapeutics and Clinical Risk Management 2007, 3:989-998
17 January 2007
Analysis of adherence to national nosocomial pneumonia treatment guidelines
Edward H Eiland III, Kurt A Wargo, Wayne Hamm, Ali AM Hassoun
Therapeutics and Clinical Risk Management 2007, 3:983-988
17 January 2007
Long-term safety and effectiveness of sildenafil citrate in men with erectile dysfunction
James G McMurray, Robert A Feldman, Stephen M Auerbach, Herb DeRiesthal, Neal Wilson et al
Therapeutics and Clinical Risk Management 2007, 3:975-981
17 January 2007
Editorial: This issue of Therapeutics and Clinical Risk Management... ||Free Paper||
Garry M Walsh
Therapeutics and Clinical Risk Management 2007, 3:973-974
17 January 2007
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
